Al-Ola Abdallah

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Multiple Myeloma

Top Venues

British journal of haematology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Danai Dima, Aliya Rashid, James A Davis, Leyla Shune, Al-Ola Abdallah, Hong Li, Shaun DeJarnette, Jack Khouri, Louis Williams, Hamza Hashmi, Shahzad Raza, Joseph McGuirk, Faiz Anwer, Nausheen Ahmed
Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre study. British journal of haematology 204 (4) (2024)
Danai Dima, Aliya Rashid, James A Davis, Leyla Shune, Al-Ola Abdallah, Hong Li, Shaun DeJarnette, Jack Khouri, Louis Williams, Hamza Hashmi, Shahzad Raza, Joseph McGuirk, Faiz Anwer, Nausheen Ahmed
Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre study. British journal of haematology 204 (4) (2024)
Muhammad Umair Mushtaq, Moazzam Shahzad, Muhammad Kashif Amin, Forat Lutfi, Shaun DeJarnette, Joe S Al-Ramahi, Kevin Li, Nausheen Ahmed, Rajat Bansal, Haitham Abdelhakim, Leyla Shune, Al-Ola Abdallah, Sunil H Abhyankar, Joseph P McGuirk, Anurag K Singh
Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation. Leukemia & lymphoma 65 (4) (2024)
Muhammad Umair Mushtaq, Moazzam Shahzad, Muhammad Kashif Amin, Forat Lutfi, Shaun DeJarnette, Joe S Al-Ramahi, Kevin Li, Nausheen Ahmed, Rajat Bansal, Haitham Abdelhakim, Leyla Shune, Al-Ola Abdallah, Sunil H Abhyankar, Joseph P McGuirk, Anurag K Singh
Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation. Leukemia & lymphoma 65 (4) (2024)
Danai Dima, Aliya Rashid, James A Davis, Leyla Shune, Al-Ola Abdallah, Hong Li, Shaun DeJarnette, Jack Khouri, Louis Williams, Hamza Hashmi, Shahzad Raza, Joseph McGuirk, Faiz Anwer, Nausheen Ahmed
Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre study. British journal of haematology 204 (4) (2024)
Danai Dima, Aliya Rashid, James A Davis, Leyla Shune, Al-Ola Abdallah, Hong Li, Shaun DeJarnette, Jack Khouri, Louis Williams, Hamza Hashmi, Shahzad Raza, Joseph McGuirk, Faiz Anwer, Nausheen Ahmed
Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre study. British journal of haematology (2024)
Muhammad Umair Mushtaq, Moazzam Shahzad, Muhammad Kashif Amin, Forat Lutfi, Shaun DeJarnette, Joe S Al-Ramahi, Kevin Li, Nausheen Ahmed, Rajat Bansal, Haitham Abdelhakim, Leyla Shune, Al-Ola Abdallah, Sunil H Abhyankar, Joseph P McGuirk, Anurag K Singh
Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation. Leukemia & lymphoma (2024)
Al-Ola Abdallah, Ghulam Rehman Mohyuddin, Nausheen Ahmed, Meera Mohan, Wei Cui, Leyla Shune, Zahra Mahmoudjafari, Joseph McGuirk, Siddhartha Ganguly, Shebli Atrash
Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease. EJHaem 2 (4) (2021)